Synthesis of 1,2,3-triazole derivatives and in Vitro antifungal evaluation on Candida strains

Molecules

Volumn 17, Issue 5, 2012, Pages 5882-5892

  Lima Neto, Reginaldo G ^a   Cavalcante, Nery N M ^b   Srivastava, Rajendra M ^b   Mendonça Jr , Francisco J B ^c   Wanderley, Almir G ^b   Neves, Rejane P ^a   Dos Anjos, Janaína V ^b  

^a DEPARTAMENTO DE MICOLOGIA   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^c STATE UNIVERSITY OF PARAÍBA   (Brazil)

Author keywords

1,2,3 triazoles; Antifungal activity; Candida spp.; Click chemistry

Indexed keywords

ANTIFUNGAL AGENT; AZIDE; MICONAZOLE; PROPANOL; TRIAZOLE DERIVATIVE;

ANIMAL; ARTICLE; CANDIDA; CHEMISTRY; CLICK CHEMISTRY; DRUG DESIGN; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; MALE; MICROBIOLOGICAL EXAMINATION; RAT; STRUCTURE ACTIVITY RELATION; SYNTHESIS; WISTAR RAT;

ANIMALS; ANTIFUNGAL AGENTS; AZIDES; CANDIDA; CLICK CHEMISTRY; DRUG DESIGN; MALE; MICONAZOLE; MICROBIAL SENSITIVITY TESTS; PROPANOLS; RATS; RATS, WISTAR; STRUCTURE-ACTIVITY RELATIONSHIP; TRIAZOLES;

EID: 84861488402     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules17055882     Document Type: Article

References (33)

1. Lopez-Martinez, R. Candidosis, a new challenge. Clin. Dermatol. 2010, 6, 178-184.
2. Chen, A.; Sobel, J.D. Emerging azole antifungals. Expert Opin. Emerg. Drugs 2005, 10, 21-33.
3. Rybak, M.J.; Akins, R.L. Emergence of methicillin-resistant Staphylococcus aureus with intermediate lycopeptide resistance: clinical significance and treatment options. Drugs 2001, 6, 1-7.
4. Sheehan, D.J.; Hitchcock, C.A.; Sibley, C.M. Current and emerging azole antifungal agents. Clin. Microbiol. Rev. 1999, 12, 40-79.
5. Wei, Q.L.; Zhang, S.S.; Gao, J.; Li, W.H.; Xu, L.Z.; Yu, Z.G. Synthesis and QSAR studies of novel triazole compounds containing thioamide as potential antifungal agents. Bioorg. Med. Chem. 2006, 14, 7146-7153.
6. Warn, P.A.; Sharp, A.; Parmar, A.; Majithiya, J.; Denning, D.W.; Hope, W.W. Pharmacokinetics and pharmacodynamics of a novel triazole, isavuconazole: Mathematical modeling, importance of tissue concentrations, and impact of immune status on antifungal effect. Antimicrob. Agents Chemother. 2009, 53, 3453-3461.
7. Zou, Y.; Zhao, Q.; Liao, J.; Hua, H.; Yu, S.; Chai, X.; Xu, M.; Wua, Q. New triazole derivatives as antifungal agents: Synthesis via click reaction, in vitro evaluation and molecular docking studies. Bioorg. Med. Chem. Lett. 2012, 22, 2959-2962.
8. Ulusoy, N.; Gursoy, A.; Otuk, G. Synthesis and antimicrobial activity of some 1,2,4-triazole-3- mercaptoacetic acid derivatives. Farmaco 2001, 56, 947-952.
9. Demirbas, N.; Demirbas, A.; Karaoglu, S.A. Synthesis and biological activities of new 1,2,4-triazol-3-one derivatives. Bioorg. Khim. 2005, 31, 430-440.
10. Bagihalli, G.B.; Avaji, P.G.; Patil, S.A.; Badami, P.S. Synthesis, spectral characterization, in vitro antibacterial, antifungal and cytotoxic activities of Co(II), Ni(II) and Cu(II) complexes with 1,2,4-triazole Schiff bases. Eur. J. Med. Chem. 2008, 43, 2639-2649.
11. Karthikeyan, M.S.; Prasad, D.J.; Poojary, B.; Bhat, K.S.; Holla, B.S.; Kumari, N.S. Synthesis and biological activity of Schiff and Mannich bases bearing 2,4-dichloro-5-fluorophenyl moiety. Bioorg. Med. Chem. 2006, 14, 7482-7489.
12. Dabak, K.; Sezer, O.; Akar, A.; Anac, O. Synthesis and investigation of tuberculosis inhibition activities of some 1,2,3-triazole derivatives. Eur. J. Med. Chem. 2003, 38, 215-218.
13. Shanmugavelan, P.; Nagarajan, S.; Sathishkumar, M.; Ponnuswamy, A.; Yogeeswari, P.; Sriram, D. Efficient synthesis and in vitro antitubercular activity of 1,2,3-triazolesas inhibitors of Mycobacterium tuberculosis. Bioorg. Med. Chem. Lett. 2011, 21, 7273-7276.
14. Joshi, S.; Khosla, N.; Tiwari, P. In vitro study of some medicinally important Mannich bases derived from antitubercular agent. Bioorg. Med. Chem. 2004, 12, 571-576.
15. Kai, H.; Hinou, H.; Nishimura, S.-I. Aglycone-focused randomization of 2-difluoromethylphenyltype sialoside suicide substrates for neuraminidases. Bioorg. Med. Chem. 2012, 20, 2739-2746.
16. Holla, B.S.; Veerendra, B.; Shivananda, M.K.; Poojary, B. Synthesis, characterization and anticancer activity studies on some Mannich bases derived from 1,2,4-triazoles. Eur. J. Med. Chem. 2003, 38, 759-767.
17. Tiew, K.-C.; Dou, D.; Teramoto, T.; Lai, H.; Alliston, K.R.; Lushington, G.H.; Padmanabhan, R.; Groutas, W.C. Inhibition of Dengue virus and West Nile virus proteases by click chemistryderived benz[d]isothiazol-3(2H)-one derivatives. Bioorg. Med. Chem. 2012, 20, 1213-1221.
18. Turan-Zitouni, G.; Kaplancikli, Z.A.; Erol, K.; Kilic, F.S. Synthesis and analgesic activity of some triazoles and triazolo-thiadiazines. Farmaco 1999, 54, 218-223.
19. He, J.; Feng, L.; Li, J.; Tao, R.; Wang, F.; Liao, X.; Sun, Q.; Long, Q.; Ren, Y.; Wan, J.; He, H. Design, synthesis and biological evaluation of novel 2-methylpyrimidine-4-ylamine derivatives as inhibitors of Escherichia coli pyruvate dehydrogenase complex E1. Bioorg. Med. Chem 2012, 20, 1665-1670.
20. Oh, K.; Yamada, K.; Asami, T.; Yoshizawa, Y. Synthesis of novel brassinosteroid biosynthesis inhibitors based on the ketoconazole scaffold. Bioorg. Med. Chem. Lett. 2012, 22, 1625-1628.
21. Malolanarasimhan, K.; Lai, C.C.; Kelley, J.A.; Iaccarino, L.; Reynolds, D.; Young, H.A.; Marquez, V.E. Synthesis and biological study of a flavone acetic acid analogue containing an azido reporting group designed as a multifunctional binding site probe. Bioorg. Med. Chem. 2005, 13, 2717-2722.
22. Lee, B.Y.; Park, S.R.; Jeon, H.B.; Kim, K.S. A new solvent system for efficient synthesis of 1,2,3-triazoles. Tetrahedron Lett. 2006, 47, 5105-5109.
23. dos Anjos, J.V.; Sinou, D.; de Melo, S.J.; Srivastava, R.M. Synthesis of glycosyl-triazole linked 1,2,4-oxadiazoles. Carbohydr. Res. 2007, 342, 2440-2449.
24. Himo, F.; Lovell, T.; Hilgraf, H.; Rostovtsev, V.V.; Noodleman, L.; Sharpless, K.B.; Fokin, V.V. Copper(I)-catalyzed synthesis of azoles. DFT study predicts unprecedented reactivity and intermediates. J. Am. Chem. Soc. 2005, 127, 210-216.
25. dos Anjos, J.V.; Neves Filho, R.A.W.; Nascimento, S.C.; Srivastava, R.M.; Melo, S.J.; Sinou, D. Synthesis and cytotoxic profile of glycosyl triazole linked to 1,2,4-oxadiazole moiety at C-5 through a straight-chain carbon and oxygen atoms. Eur. J. Med. Chem. 2009, 44, 3571-3576.
26. Wang, W.; Sheng, C.; Che, X.; Ji, H.; Cao, Y.; Miao, Z.; Yao, J.; Zhang, W. Discovery of highly potent novel antifungal azoles by structure-based rational design. Bioorg. Med. Chem. Lett. 2009, 19, 5965-5969.
27. Wang, W.; Wang, S.; Liu, Y.; Dong, G.; Cao, Y.; Miao, Z.; Yao, J.; Zhang, W.; Sheng, C. Novel conformationally restricted triazole derivatives with potent antifungal activity. Eur. J. Med. Chem. 2010, 45, 6020-6026.
28. Lorke, D. A new approach to practical acute toxicity testing. Arch. Toxicol. 1983, 54, 275-287.
29. Sherf, A.F. A method for maintaining Phytomonas sepedomica for long periods without transfer. Phytopathology 1943, 31, 30-32.
30. de Hoog, G.S.; Guarro, J.; Gene, J.; Figueras, M.J. Atlas of Clinical Fungi, 2nd ed.; Centraalbureau voor Schimmelcultures: Utrecht, The Netherlands and Universitat Rovira i Virgili: Reus, Spain, 2000; p. 1124.
31. Clinical Laboratory Standards Institute (CLSI). Reference Method for Broth Dilution Testing of Yeasts; Approved standard-third edition M27-A3; CLSI: Wayne, PA, USA, 2008.
32. Malone, M.H. Pharmacological Approaches to Natural Products Screening and Evaluation. In New Natural Products and Plant Drugs with Pharmacological, Biological or Therapeutical Activity; Wagner, H., Wolf, P., Eds; Springer-Verlag: Berlin, Germany, 1977; pp. 23-53.
33. Organisation for Economic Co-operation and Development (OECD). OECD Guideline for Testing of Chemicals: Acute Oral Toxicity-Up-and-Down Procedure; n 425; OECD Publishing: Paris, France, 2001.